|
Re: chatted with Sarah yesterday afternoon...
|
4
|
Resverlogix Corp.
|
Jan 19, 2022 12:48PM
|
|
Re: Short squeeze?
|
3
|
Resverlogix Corp.
|
Jan 19, 2022 12:16PM
|
|
Re: Edmonton Journal Article
|
1
|
Resverlogix Corp.
|
Jan 19, 2022 12:03PM
|
|
Re: Resverlogix Announces Commencement of Patient Enrollment and Dosing in a Phase 2b Trial for a Promising Canadian-Developed COVID-19 Treatment
|
6
|
Resverlogix Corp.
|
Jan 18, 2022 09:52AM
|
|
Re: Buy Canadian !!!
|
1
|
Resverlogix Corp.
|
Jan 14, 2022 04:10PM
|
|
Re: Buy Canadian !!!
|
1
|
Resverlogix Corp.
|
Jan 14, 2022 03:30PM
|
|
Re: Buy Canadian !!!
|
4
|
Resverlogix Corp.
|
Jan 14, 2022 02:53PM
|
|
Re: IR response
|
4
|
Resverlogix Corp.
|
Jan 12, 2022 07:55AM
|
|
"ORI" SEDI Insider Report
|
4
|
Resverlogix Corp.
|
Jan 11, 2022 09:08AM
|
|
Re: Eversana ValuationCaseStudy
|
2
|
Resverlogix Corp.
|
Jan 10, 2022 08:36AM
|
|
Re: Eversana ValuationCaseStudy
|
6
|
Resverlogix Corp.
|
Jan 09, 2022 12:20PM
|
|
Re: Eversana ValuationCaseStudy
|
1
|
Resverlogix Corp.
|
Jan 08, 2022 08:06AM
|
|
Re: Long term risks associated with covid
|
5
|
Resverlogix Corp.
|
Jan 06, 2022 12:21PM
|
|
Re: Update
|
6
|
Resverlogix Corp.
|
Dec 17, 2021 01:16AM
|
|
Re: The Critical Role of Management!
|
1
|
Resverlogix Corp.
|
Dec 16, 2021 09:59AM
|
|
Re: Scientists Develop a New Molecule That Blocks COVID-19 Infection.
|
3
|
Resverlogix Corp.
|
Dec 15, 2021 08:54AM
|
|
Re: Hope Remains -- Pfizer's pill gets downgrade to 30% effectiveness
|
1
|
Resverlogix Corp.
|
Dec 14, 2021 11:10AM
|
|
Form 45-106F1 Report of Exempt Distribution Dec 13, 2021
|
2
|
Resverlogix Corp.
|
Dec 14, 2021 06:21AM
|
|
Corporate Update Webcast and Conference Call December 16, 2021 @ 2 PM MST
|
5
|
Resverlogix Corp.
|
Dec 13, 2021 06:12AM
|
|
Re: Question for posters
|
2
|
Resverlogix Corp.
|
Dec 12, 2021 11:12AM
|
